Pulmonary Fibrosis
"Pulmonary Fibrosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
Descriptor ID |
D011658
|
MeSH Number(s) |
C08.381.765
|
Concept/Terms |
Pulmonary Fibrosis- Pulmonary Fibrosis
- Pulmonary Fibroses
- Fibroses, Pulmonary
- Fibrosis, Pulmonary
Alveolitis, Fibrosing- Alveolitis, Fibrosing
- Alveolitides, Fibrosing
- Fibrosing Alveolitides
- Fibrosing Alveolitis
- Hamman-Rich Syndrome
- Hamman Rich Syndrome
- Syndrome, Hamman-Rich
|
Below are MeSH descriptors whose meaning is more general than "Pulmonary Fibrosis".
Below are MeSH descriptors whose meaning is more specific than "Pulmonary Fibrosis".
This graph shows the total number of publications written about "Pulmonary Fibrosis" by people in this website by year, and whether "Pulmonary Fibrosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 | 1997 | 2 | 0 | 2 | 1998 | 1 | 1 | 2 | 2001 | 2 | 1 | 3 | 2002 | 8 | 1 | 9 | 2003 | 4 | 0 | 4 | 2004 | 5 | 1 | 6 | 2005 | 11 | 1 | 12 | 2006 | 3 | 4 | 7 | 2007 | 11 | 3 | 14 | 2008 | 8 | 1 | 9 | 2009 | 5 | 0 | 5 | 2010 | 4 | 1 | 5 | 2011 | 8 | 1 | 9 | 2012 | 8 | 1 | 9 | 2013 | 2 | 3 | 5 | 2014 | 7 | 1 | 8 | 2015 | 4 | 0 | 4 | 2016 | 4 | 5 | 9 | 2017 | 11 | 2 | 13 | 2018 | 6 | 0 | 6 | 2019 | 7 | 2 | 9 | 2020 | 6 | 1 | 7 | 2021 | 5 | 1 | 6 | 2022 | 5 | 0 | 5 | 2023 | 10 | 0 | 10 | 2024 | 12 | 4 | 16 | 2025 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Pulmonary Fibrosis" by people in Profiles.
-
Rose JA, Steele MP, Kosak Lopez EJ, Axelsson GT, Galecio Chao AG, Waich A, Regan K, Gulati S, Maeda AH, Sultana S, Cutting C, Tukpah AC, Synn AJ, Rice MB, Goldberg HJ, Lee JS, Lynch DA, Putman RK, Hatabu H, Raby BA, Schwartz DA, Rosas IO, Hunninghake GM. Protein biomarkers of interstitial lung abnormalities in relatives of patients with pulmonary fibrosis. Eur Respir J. 2025 Jun; 65(6).
-
Wilson TM, Bolt M, Stahly A, Lee JS, Bang TJ, Sachs PB, Deane KD, Humphries SM, Solomon JJ, Demoruelle MK. Transforming growth factor-beta is increased in sputum from individuals with rheumatoid arthritis-associated pulmonary fibrosis. Rheumatology (Oxford). 2025 Jun 01; 64(6):3989-3995.
-
Thorndyke HF, Lundberg EP, Ortiz Gaxon E, Dawson MM, Mason EC, Hollaway JM, Vladar EK, Coronado Escobar D, Majka SM. Development of novel technology for the visualization and quantitation of angiogenesis and the alveolar-capillary network in a mouse model of fibrosis. Am J Physiol Lung Cell Mol Physiol. 2025 Jun 01; 328(6):L866-L876.
-
King EM, Zhao Y, Moore CM, Steinhart B, Anderson KC, Vestal B, Moore PK, McManus SA, Evans CM, Mould KJ, Redente EF, McCubbrey AL, Janssen WJ. Gpnmb and Spp1 mark a conserved macrophage injury response masking fibrosis-specific programming in the lung. JCI Insight. 2024 Dec 20; 9(24).
-
Solomon JJ, Hallowell RW, Ganslandt C, Shull JG, Bengtsson T, Ganslandt J, Horton MR. A digital therapy targeting anxiety in pulmonary fibrosis: A decentralized randomized controlled trial. Respirology. 2025 Mar; 30(3):253-261.
-
Griese M, Kurland G, Cidon M, Deterding RR, Epaud R, Nathan N, Schwerk N, Warburton D, Weinman JP, Young LR, Deutsch GH. Pulmonary fibrosis may begin in infancy: from childhood to adult interstitial lung disease. Thorax. 2024 Nov 14; 79(12):1162-1172.
-
Humphries SM, Adegunsoye A, Demoruelle MK, Wei Kam ML, Amigues I, Bang TJ, Teague SD, Lynch DA, Chung JH, Strek ME, Swigris JJ, Solomon JJ. Quantitative CT Scan Analysis in Rheumatoid Arthritis-Related Interstitial Lung Disease. Chest. 2025 May; 167(5):1428-1439.
-
Channick JE, Swigris J. Cough in Fibrotic Interstitial Lung Disease: Effects and Implications. Am J Respir Crit Care Med. 2024 Oct 15; 210(8):975-976.
-
O'Callaghan M, Tarling EJ, Bridges JP, Redente EF, Byrne AJ, Keane MP, McCarthy C. Reexamining the Role of Pulmonary Lipids in the Pathogenesis of Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2024 Oct; 71(4):407-419.
-
Ting C, Konopka K, Benedeck RE, Riches DWH, Redente EF, Oldham JM, Zemans RL. Biomarkers Unveil Insights into Pathology of Transitional Epithelial States in Pulmonary Fibrosis. Am J Respir Crit Care Med. 2024 Sep 01; 210(5):687-690.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|